» Articles » PMID: 12876307

The Complete Genome Sequence of Severe Acute Respiratory Syndrome Coronavirus Strain HKU-39849 (HK-39)

Overview
Specialty Biology
Date 2003 Jul 24
PMID 12876307
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The complete genomic nucleotide sequence (29.7kb) of a Hong Kong severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) strain HK-39 is determined. Phylogenetic analysis of the genomic sequence reveals it to be a distinct member of the Coronaviridae family. 5' RACE assay confirms the presence of at least six subgenomic transcripts all containing the predicted intergenic sequences. Five open reading frames (ORFs), namely ORF1a, 1b, S, M, and N, are found to be homologues to other CoV members, and three more unknown ORFs (X1, X2, and X3) are unparalleled in all other known CoV species. Optimal alignment and computer analysis of the homologous ORFs has predicted the characteristic structural and functional domains on the putative genes. The overall nucleotides conservation of the homologous ORFs is low (<5%) compared with other known CoVs, implying that HK-39 is a newly emergent SARS-CoV phylogenetically distant from other known members. SimPlot analysis supports this finding, and also suggests that this novel virus is not a product of a recent recombinant from any of the known characterized CoVs. Together, these results confirm that HK-39 is a novel and distinct member of the Coronaviridae family, with unknown origin. The completion of the genomic sequence of the virus will assist in tracing its origin.

Citing Articles

Pharmacological inhibition of bromodomain and extra-terminal proteins induces an NRF-2-mediated antiviral state that is subverted by SARS-CoV-2 infection.

Mhlekude B, Postmus D, Stenzel S, Weiner 3rd J, Jansen J, Zapatero-Belinchon F PLoS Pathog. 2023; 19(9):e1011657.

PMID: 37747932 PMC: 10629670. DOI: 10.1371/journal.ppat.1011657.


Nonproductive exposure of PBMCs to SARS-CoV-2 induces cell-intrinsic innate immune responses.

Kazmierski J, Friedmann K, Postmus D, Emanuel J, Fischer C, Jansen J Mol Syst Biol. 2022; 18(8):e10961.

PMID: 35975552 PMC: 9382356. DOI: 10.15252/msb.202210961.


SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.

Natarelli L, Virgili F, Weber C Int J Mol Sci. 2021; 22(22).

PMID: 34830125 PMC: 8620514. DOI: 10.3390/ijms222212243.


Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5'UTR of SARS-CoV-2.

Baldassarre A, Paolini A, Bruno S, Felli C, Tozzi A, Masotti A Epigenomics. 2020; 12(15):1349-1361.

PMID: 32875809 PMC: 7466951. DOI: 10.2217/epi-2020-0162.


SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.

Li Y, Wang H, Tang X, Fang S, Ma D, Du C J Virol. 2020; 94(22).

PMID: 32847856 PMC: 7592233. DOI: 10.1128/JVI.01283-20.